Entry |
|
Name |
Pagoclone (USAN/INN); Bextra (TN) |
Formula |
C23H22ClN3O2
|
Exact mass |
407.1401
|
Mol weight |
407.89
|
Structure |

|
Class |
Neuropsychiatric agent
DG01836 Non-benzodiazepine sedative-hypnotics
DG01567 GABA-A receptor agonist
|
Efficacy |
Antianxiety |
Target |
|
Pathway |
hsa04080 | Neuroactive ligand-receptor interaction |
|
Interaction |
|
Structure map |
|
Brite |
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01836 Non-benzodiazepine sedative-hypnotics
D02616 Pagoclone
DG01567 GABA-A receptor agonist
D02616 Pagoclone
Target-based classification of drugs [BR:br08310]
Ion channels
Ligand-gated ion channels
GABA (ionotropic)
GABR
D02616 Pagoclone (USAN/INN)
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 29
1 C8x C 7.9100 -17.0800
2 C8x C 7.9100 -18.4800
3 C8x C 9.1700 -19.1800
4 C8y C 10.3600 -18.4800
5 C8y C 10.3600 -17.0800
6 C8x C 9.1700 -16.3800
7 C1y C 11.6900 -18.9000
8 N1y N 12.5300 -17.7800
9 C5x C 11.6900 -16.5900
10 O5x O 12.1100 -15.2600
11 C8y C 13.8600 -17.7800
12 C8x C 14.5600 -18.9700
13 C8x C 15.9600 -18.9700
14 C8y C 16.7300 -17.7800
15 C8y C 15.9600 -16.5200
16 N5x N 14.5600 -16.5200
17 C8x C 18.1300 -17.7800
18 C8x C 18.8300 -16.5200
19 C8y C 18.1300 -15.3300
20 N5x N 16.7300 -15.3300
21 X Cl 18.8300 -14.0700
22 C1b C 11.6900 -20.3000
23 C5a C 12.9053 -20.9951
24 O5a O 14.0937 -20.3023
25 C1b C 12.9111 -22.3997
26 C1b C 14.1029 -23.0815
27 C1c C 14.0390 -24.4995
28 C1a C 12.8207 -25.1318
29 C1a C 15.2408 -25.2677
BOND 32
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 4 7 1
8 7 8 1
9 8 9 1
10 5 9 1
11 9 10 2
12 8 11 1
13 11 12 2
14 12 13 1
15 13 14 2
16 14 15 1
17 15 16 2
18 11 16 1
19 14 17 1
20 17 18 2
21 18 19 1
22 19 20 2
23 15 20 1
24 19 21 1
25 7 22 1
26 22 23 1
27 23 24 2
28 23 25 1
29 25 26 1
30 26 27 1
31 27 28 1
32 27 29 1
|